(Q39276875)

10 September 2017

title

'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis (English)

1 reference

10 September 2017

1 reference

Maria Pina Frattaruolo

Maria Pina Frattaruolo

5

0 references

Paolo Vercellini

Paolo Vercellini

1

0 references

Edgardo Somigliana

Edgardo Somigliana

3

0 references

Luigi Fedele

Luigi Fedele

6

0 references

Paola Viganò

4

Paola Viganò

1 reference

10 September 2017

Piergiorgio Crosignani

2

PierGiorgio Crosignani

1 reference

10 September 2017

language of work or name

English

0 references

publication date

11 November 2010

1 reference

10 September 2017

1 reference

10 September 2017

volume

26

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

3-13

1 reference

Anastrazole and oral contraceptives: a novel treatment for endometriosis

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Aromatase inhibitors: the next generation of therapeutics for endometriosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Inflammatory status influences aromatase and steroid receptor expression in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Investigational drugs for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Hormonal contraception and risk of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Absence of aromatase protein and mRNA expression in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Advances in the management of endometriosis: an update for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Extracts from the "clinical evidence". Endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Emerging drugs for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Dynamics and significance of placebo response in primary dysmenorrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Pharmacological treatment of endometriosis: experience with aromatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Current pharmacotherapy for endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Letrozole and norethisterone acetate in colorectal endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Economic burden of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Clinical practice. Endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Recurrence of endometriosis and its control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

A call for more transparency of registered clinical trials on endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Endometriosis: the way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Chocolate cysts from ovarian follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

ESHRE guideline for the diagnosis and treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Publication of clinical trials supporting successful new drug applications: a literature analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Emerging drugs in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Reproductive history and endometriosis among premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

The fight against disease mongering: generating knowledge for action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

New medical treatments for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Advances in the medical management of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Priorities for endometriosis research: recommendations from an international consensus workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Endometriosis: cost estimates and methodological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Progestogens for endometriosis: forward to the past

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Endometriosis: current and future medical therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

The effect of surgery for symptomatic endometriosis: the other side of the story.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Repetitive surgery for recurrent symptomatic endometriosis: what to do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Endometriosis: current therapies and new pharmacological developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Medical treatment for rectovaginal endometriosis: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

New drugs in development for the treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

‘Blood On The Tracks’ from corpora lutea to endometriomas*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ302

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEQ302

1 reference

10 September 2017

1 reference